Faculty Member	Research Interest
Christine Ambrosone, PhD, Chair, Department of Cancer Prevention and Control	diet, chemical carcinogens and steroid hormones in cancer risk, especially for breast, prostate and lung
Anne Marie W. Block, PhD, Laboratory Director, Cytogenetics Laboratory	chromosome abnormalities in B-cell lymphoproliferative; mitogenic stimulation of human B cells; fluorescence in situ hybridization (FISH)
Paul Bogner, MD, Staff Physician Assistant Professor of Oncology Department of Pathology and Laboratory Medicine	thoracic oncology, including the histological and molecular diagnosis, classification and staging of lung tumors
Richard T. Cheney, MD, Chair, Department of Pathology and Laboratory Medicine	Photodynamic Therapy, cutaneous mast cells, dermatopathology
K Michael Cummings, PhD, Chair, Department of Health Behavior	Tobacco control, tobacco cessation and nicotine addiction
Barbara Foster*, PhD, Assistant Member, Department of Pharmacology and Experimental Therapeutics	Vitamin D analogs, selenium, dendritic cell vaccine, mechanisms of prostate cancer development
Theresa Hahn, Assistant Member, Clinical Research, Department of Medicine	clinical epidemiology, outcomes research, evidence-based medicine; blood and marrow transplantation; and infectious disease epidemiology
Andrew Hyland, PhD, Research Scientist, Department of Health Behavior Division of Cancer Prevention & Population Sciences	evaluating the impact of policies aimed at reducing the morbidity and mortality associated with the use of tobacco products
Clement Ip, PhD, Chair, Department of Chemoprevention	cancer chemoprevention by selenium
Surabhi Kakati, PhD, Assistant Research Director, Cytogenetics Laboratory	chromosomal abnormalities in leukemias, lymphomas and solid tumors
Sue Leong, PhD, Director, The Cancer Pathology and Prevention Graduate Training Program	new drug development, clinical trials, medical ethics, continuing medical education and immunology
Martin Mahoney, MD, PhD, Director, Cancer Prevention & Detection Center, Employee Health Clinic; Research Scientist, Department of Cancer Prevention & Population Sciences	cancer screening utilization and promotion; effect of Chernobyl-related radiation exposure on the risk of leukemia; smoking cessation
James R. Marshall, PhD, Senior Vice President, Cancer Prevention and Population Sciences	selenium for chemoprevention, biomarkers to measure chemoprevention and molecular epidemiology
Susan McCann, PhD, Assistant Member Division of Cancer Prevention and Population Sciences	nutritional and molecular epidemiology including the impact of diet on cancers of the reproductive organs
Philip McCarthy, MD, Chief, Division of Blood and Marrow Transplantation, Department of Medicine	health effects of radiation exposure, modulation of graft versus host disease and of chemotherapy toxicity, blood and marrow stem cell isolation, immune modulation after transplantation
Paulette Mhawech-Fauceglia, MD, Associate Professor of Oncology, Department of Pathology and Laboratory Medicine	gynecologic malignancies, particularly the molecular characterization of endometrial and ovarian tumors
Kirsten Moysich, PhD, Associate Member, Department of Epidemiology	Chernobyl nuclear accident, aspirin and NSAIDs for chemoprevention, epidemiology
Richard O’Connor, PhD, Department of Health Behavior, Division of Cancer Prevention and Population Sciences	mechanisms of tobacco addiction including patterns of tobacco use, development of unobtrusive and minimally invasive measures of tobacco exposure in humans
Lakshmi Pendyala, PhD, Facility Director, Pharmacokinetics/Pharmacodynamics	drug action and resistance mechanisms of platinum complexes
Mary Reid, PhD, Department of Cancer Prevention and Population Sciences	early detection and chemoprevention of lung and head and neck cancers
Sheila N. J. Sait, PhD, Research Director, Cytogenetics Laboratory	double minute chromosomes (dms) and homogeneously staining regions (hsr) in leukemia and MDS
Gary J. Smith, PhD, Co-Leader, Prostate Program, Distinguished Professor, Oncology, Department of Urologic Oncology	prevention and treatment of prostate cancer; prostatic stem cells, angiogenesis; racial differences in prostate cancer mortality.
Petr Starostik, MD, Clinical Chief, Molecular Diagnostics	tumor suppressor gene, oncogene aberrations, new molecular diagnostic tests
Daniel Stoler, PhD, Assistant Member, Department of Cancer Genetics	genomic instability in tumor progression
Paul K. Wallace, PhD, Director of Flow Cytometry Laboratory	flow cytometry, immunotherapy of cancer
Yuesheng Zhang, PhD, Professor of Oncology and Member, Department of Cancer Prevention and Control	chemoprevention of bladder cancer, drug development in cancer prevention
Hua Zhao, PhD, Assistant Member, Department of Epidemiology and Cancer Prevention, Department of Cancer Prevention and Population Science	molecular epidemiology and how individual’s genotypic and phenotypic variations might modify cancer risk

*Joint Appointment